WHO updates its treatment guidelines to include new antiviral medicine molnupiravir
The World Health Organization (WHO) has updated its living guidelines on COVID-19 therapeutics to include a conditional recommendation on molnupiravir, a new antiviral medicine.
This is the first oral antiviral drug to be included in the…